RANDOMISED CONTROLLED TRIAL OF AZATHIOPRINE WITHDRAWAL IN AUTOIMMUNE CHRONIC ACTIVE HEPATITIS
- 1 March 1985
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 325 (8430) , 668-670
- https://doi.org/10.1016/s0140-6736(85)91329-7
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Relapse Following Treatment Withdrawal in Patients with Autoimmune Chronic Active HepatitisHepatology, 1983
- Corticosteroid-Treated Chronic Active Hepatitis in RemissionNew England Journal of Medicine, 1981
- Hypersensitivity and jaundice due to azathioprinePublished by Oxford University Press (OUP) ,1980
- Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared.Gut, 1975
- RISK OF CANCER IN RENAL-TRANSPLANT RECIPIENTSThe Lancet, 1973
- Immunosuppressive activity in patients with active chronic hepatitis and primary biliary cirrhosis treated with azathioprineGut, 1972
- Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic HepatitisQJM: An International Journal of Medicine, 1971
- TREATMENT OF ACTIVE CHRONIC HEPATITIS AND LUPOID HEPATITIS WITH 6-MERCAPTOPURINE AND AZOTHIOPRINEThe Lancet, 1964